These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 11926785

  • 21. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.
    Bartley PC, Bogoev M, Larsen J, Philotheou A.
    Diabet Med; 2008 Apr; 25(4):442-9. PubMed ID: 18387078
    [Abstract] [Full Text] [Related]

  • 22. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.
    Ahmed AB, Home PD.
    Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735
    [Abstract] [Full Text] [Related]

  • 23. Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.
    Kristensen PL, Tarnow L, Bay C, Nørgaard K, Jensen T, Parving HH, Perrild H, Beck-Nielsen H, Christiansen JS, Thorsteinsson B, Pedersen-Bjergaard U.
    Diabet Med; 2017 May; 34(5):625-631. PubMed ID: 28099755
    [Abstract] [Full Text] [Related]

  • 24. Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin.
    Herz M, Arora V, Sun B, Ferguson SC, Bolli GB, Frier BM.
    Diabet Med; 2002 Nov; 19(11):917-23. PubMed ID: 12421428
    [Abstract] [Full Text] [Related]

  • 25. Association of Initiation of Basal Insulin Analogs vs Neutral Protamine Hagedorn Insulin With Hypoglycemia-Related Emergency Department Visits or Hospital Admissions and With Glycemic Control in Patients With Type 2 Diabetes.
    Lipska KJ, Parker MM, Moffet HH, Huang ES, Karter AJ.
    JAMA; 2018 Jul 03; 320(1):53-62. PubMed ID: 29936529
    [Abstract] [Full Text] [Related]

  • 26. Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.
    Stades AM, Hoekstra JB, van den Tweel I, Erkelens DW, Holleman F, STABILITY Study Group.
    Diabetes Care; 2002 Apr 03; 25(4):712-7. PubMed ID: 11919130
    [Abstract] [Full Text] [Related]

  • 27. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.
    Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB.
    Diabetes Care; 1999 Mar 03; 22(3):468-77. PubMed ID: 10097931
    [Abstract] [Full Text] [Related]

  • 28. Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labeled randomized trial.
    Petit-Bibal C, Rothenbuhler A, Lucchini P, Aboumrad B, Castell AL, Le Fur S, Bougnères P.
    Pediatr Diabetes; 2015 Aug 03; 16(5):345-53. PubMed ID: 24888575
    [Abstract] [Full Text] [Related]

  • 29. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
    Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA.
    Diabetes Care; 2000 May 03; 23(5):639-43. PubMed ID: 10834423
    [Abstract] [Full Text] [Related]

  • 30. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial.
    Agesen RM, Kristensen PL, Beck-Nielsen H, Nørgaard K, Perrild H, Christiansen JS, Jensen T, Hougaard P, Parving HH, Thorsteinsson B, Tarnow L, Pedersen-Bjergaard U.
    Diabetes Metab; 2016 Sep 03; 42(4):249-55. PubMed ID: 27068361
    [Abstract] [Full Text] [Related]

  • 31. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J, Park G, Zimmerman J, U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Diabetes Care; 2000 Aug 03; 23(8):1137-42. PubMed ID: 10937511
    [Abstract] [Full Text] [Related]

  • 32. Split-mixed insulin regimen with human ultralente before supper and NPH (isophane) before breakfast in children and adolescents with IDDM.
    Wolfsdorf JI, Laffel LM, Pasquarello C, Vernon A, Herskowitz RD.
    Diabetes Care; 1991 Nov 03; 14(11):1100-6. PubMed ID: 1797498
    [Abstract] [Full Text] [Related]

  • 33. Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?
    Heller SR, Amiel SA, Evans ML, Kong MF, Macdonald IA, Peacey SR.
    Diabetes Obes Metab; 2002 Mar 03; 4(2):106-12. PubMed ID: 11940107
    [Abstract] [Full Text] [Related]

  • 34. Avoiding nocturnal hypoglycemia: consideration of an extra injection at bedtime.
    Norris AW, Laffel LM.
    Ann Intern Med; 2002 Apr 02; 136(7):547-9. PubMed ID: 11926791
    [No Abstract] [Full Text] [Related]

  • 35. The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.
    Standl E, Lang H, Roberts A.
    Diabetes Technol Ther; 2004 Oct 02; 6(5):579-88. PubMed ID: 15628811
    [Abstract] [Full Text] [Related]

  • 36. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
    Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, Munoz C, Newton C, Peng L, Baldwin D.
    J Clin Endocrinol Metab; 2009 Feb 02; 94(2):564-9. PubMed ID: 19017758
    [Abstract] [Full Text] [Related]

  • 37. Improved treatment satisfaction in patients with type 1 diabetes treated with insulin glargine 100U/mL versus neutral protamine Hagedorn insulin: An exploration of key predictors from two randomized controlled trials.
    Polonsky W, Traylor L, Gao L, Wei W, Ameer B, Stuhr A, Vlajnic A.
    J Diabetes Complications; 2017 Mar 02; 31(3):562-568. PubMed ID: 28040350
    [Abstract] [Full Text] [Related]

  • 38. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?
    Choudhary P, Davies C, Emery CJ, Heller SR.
    Diabet Med; 2013 Aug 02; 30(8):914-7. PubMed ID: 23672623
    [Abstract] [Full Text] [Related]

  • 39. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin.
    Chase HP, Dixon B, Pearson J, Fiallo-Scharer R, Walravens P, Klingensmith G, Rewers M, Garg SK.
    J Pediatr; 2003 Dec 02; 143(6):737-40. PubMed ID: 14657818
    [Abstract] [Full Text] [Related]

  • 40. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.
    Cengiz E, Sherr JL, Erkin-Cakmak A, Weinzimer SA, Burke EN, Sikes KA, Urban AD, Tamborlane WV.
    Endocr Pract; 2011 Dec 02; 17(6):862-6. PubMed ID: 21550949
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.